June 2026 – First Half
Research in hair loss and regrowth explores herbal hair serums and shampoos with natural ingredients like rosemary extract, rivaling minoxidil, while polyherbal oils with bhringraj and amla reduce hair fall. Non-surgical methods such as Jet Peel technology and solid microneedle boosters enhance hair density, with exosomes from salmon tissue and iontophoresis targeting androgenetic alopecia. Pharmacological studies compare finasteride and dutasteride, while quercetin and kaempferol inhibit Jak3 kinase and 5-alpha reductase type II. Advances in stem cell-based therapies and immune-competent hair follicle systems offer targeted treatments, with the M5 isolation method preserving dermal papilla cells’ trichogenic identity. The role of vitamin D in non-scarring alopecia and GLP-1 receptor agonists on hair loss highlights broader physiological factors affecting hair health.
The community intensely debates hair loss treatments, scrutinizing finasteride’s cognitive and emotional effects and side effects prompting shifts to dutasteride or topical alternatives to mitigate dizziness. Concerns about dutasteride-induced shedding and generic drug legitimacy abound, with hormonal monitoring via testing advised. Managing hair loss during steroid cycles and post-finasteride syndrome risks are pivotal. Users share experiences with RU-58841 and GHK-Cu, debating RU-58841 and oral minoxidil combinations due to heart-related side effects. Microneedling and tretinoin with minoxidil are explored for enhanced results. Advice is sought on fluridil side effects and hair transplant outcomes. The effectiveness of ketoconazole and contact reactions from topicals are discussed in the quest for solutions.